Vascepa is a prescription medication that contains icosapent ethyl, a type of omega-3 fatty acid that is used to treat high levels of triglycerides in the blood. According to the sources provided, Vascepa can be used for long-term treatment.

One source, Drug Patent Watch [1], provides information on the patent status of Vascepa. The patent for Vascepa was set to expire in 2020, indicating that the medication has been on the market for several years and has likely been used for long-term treatment by some patients.

Healthline [2] notes that Vascepa is typically used as a long-term treatment to lower triglyceride levels in patients with high levels. The medication is taken orally, usually twice a day, and is meant to be used as part of a larger treatment plan that includes lifestyle changes such as diet and exercise.

Finally, a case report published in Cureus [3] discusses the use of Vascepa in the treatment of prolonged post-infectious COVID-19 symptoms. The patient in the case report was prescribed Vascepa for long-term use to manage symptoms related to COVID-19.

Overall, the sources suggest that Vascepa can be used for long-term treatment to manage high levels of triglycerides or other conditions. However, as with any medication, it is important to follow the instructions of a healthcare provider and to monitor for any potential side effects or interactions with other medications.

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/VASCEPA
[2] https://www.healthline.com/health/drugs/vascepa
[3] https://www.cureus.com/publish/articles/92742-icosapent-ethyl-vascepa-in-the-treatment-of-prolonged-post-infectious-covid-19-symptoms/preview?token=K_GvFLfprFB2cyqJukEg&utm_campaign=added_as_coauthor&utm_medium=email&utm_source=author_mailer